TELA Bio, Inc. (TELA) Gross Margin
- Gross margin · 12 months: Value 67.81%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 67.81% | Gross profit / revenue. Period ending 2026-06-30. $54.19M ÷ $79.91M × 100 ≈ 67.81% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 54.19M USD | Gross Profit |
| Revenue | 79.91M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $54.19M | $79.91M | (m) | 67.81% |
| 2026-03-31 | $54.35M | $80.81M | (m) | 67.25% |
| 2025-12-31 | $54.34M | $80.28M | (m) | 67.69% |
| 2025-09-30 | $51.81M | $77.06M | (m) | 67.23% |
| 2025-06-30 | $50.70M | $75.32M | (m) | 67.30% |
| 2025-03-31 | $47.66M | $71.22M | (m) | 66.93% |
| 2024-12-31 | $46.49M | $69.30M | (m) | 67.08% |
| 2024-09-30 | $46.89M | $68.65M | (m) | 68.31% |
| 2024-06-30 | $44.42M | $64.74M | (m) | 68.61% |
| 2024-03-31 | $43.55M | $63.15M | (m) | 68.97% |
| 2023-12-31 | $40.11M | $58.45M | (m) | 68.62% |
| 2023-09-30 | $36.66M | $53.08M | (m) | 69.08% |
| 2023-06-30 | $33.59M | $49.18M | (m) | 68.30% |
| 2023-03-31 | $29.94M | $45.10M | (m) | 66.40% |
| 2022-12-31 | $27.04M | $41.42M | (m) | 65.30% |
| 2022-09-30 | $24.53M | $38.17M | (m) | 64.26% |
| 2022-06-30 | $21.81M | $34.66M | (m) | 62.92% |
| 2022-03-31 | $20.35M | $31.82M | (m) | 63.95% |
| 2021-12-31 | $18.81M | $29.46M | (m) | 63.85% |
| 2021-09-30 | $16.82M | $26.76M | (m) | 62.85% |
| 2021-06-30 | $15.50M | $24.41M | (m) | 63.49% |
| 2021-03-31 | $12.50M | $20.36M | (m) | 61.38% |
| 2020-12-31 | $11.23M | $18.21M | (m) | 61.68% |
| 2020-09-30 | $10.54M | $17.41M | (m) | 60.51% |
| 2020-06-30 | $9.85M | $16.07M | (m) | 61.31% |
| 2020-03-31 | $9.67M | $15.87M | (m) | 60.97% |
| 2019-12-31 | $9.27M | $15.45M | (m) | 60.03% |
| 2019-09-30 | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) |
| 2018-12-31 | $2.94M | $8.27M | (m) | 35.56% |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2017-12-31 | $2.53M | $4.25M | (m) | 59.65% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |